Download full-text PDF

Source
http://dx.doi.org/10.3928/23258160-20250220-01DOI Listing

Publication Analysis

Top Keywords

rwc update
4
update intraocular
4
intraocular inflammation
4
inflammation retinal
4
retinal pharmacotherapy
4
pharmacotherapy giant
4
giant retinal
4
retinal tear
4
tear ilm
4
ilm peeling
4

Similar Publications

JCO SEQUOIA (ClinicalTrials.gov identifier: NCT03336333) is a phase III, randomized, open-label trial that compared the oral Bruton tyrosine kinase inhibitor zanubrutinib to bendamustine plus rituximab (BR) in treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). The initial prespecified analysis (median follow-up, 26.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!